ARRIVENT BIOPHARMA INC

Ticker: AVBP CUSIP: 04272N102 Class: Common Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 742,526 Value ($000) $14,940 Avg Close $20.82 Range $17.00 - $25.82

Q3 2025

Shares 431,939 Value ($000) $7,969 Avg Close $19.65 Range $16.10 - $23.38

Q2 2025

Shares 339,196 Value ($000) $7,384 Avg Close $20.76 Range $15.47 - $25.80

Q1 2025

Shares 76,877 Value ($000) $1,421 Avg Close $24.47 Range $17.84 - $29.71

Q4 2024

Shares 207,269 Value ($000) $5,522 Avg Close $28.71 Range $23.00 - $36.37

Q3 2024

Shares 72,968 Value ($000) $1,715 Avg Close $22.70 Range $17.21 - $30.99

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	742,526	$14,940	$20.82	$17.00 - $25.82
Q3 2025	431,939	$7,969	$19.65	$16.10 - $23.38
Q2 2025	339,196	$7,384	$20.76	$15.47 - $25.80
Q1 2025	76,877	$1,421	$24.47	$17.84 - $29.71
Q4 2024	207,269	$5,522	$28.71	$23.00 - $36.37
Q3 2024	72,968	$1,715	$22.70	$17.21 - $30.99